The Determinants of Pharmaceutical Research and Development Investments ∗

@inproceedings{Civan2006TheDO,
  title={The Determinants of Pharmaceutical Research and Development Investments ∗},
  author={Abdulkadir Civan and Michael S. Landy Laurence T. Maloney},
  year={2006}
}
Our maintained hypothesis is that drug development responds to the intensity of consumer demand. We look at the distribution of drug development by disease and link this to the economic harm caused by disease as measured by mortality. Mortality data represent the net effect of human frailty and the efficacy of the existing drugs on the market. If people continue to die from a given condition then existing drugs are not perfect and there are potential profits from developing a more effective… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Market Size in I

  • D. Acemoglu, J. Linn
  • 2004
Highly Influential
3 Excerpts

Competition and Substitutability in the Swedish Pharmaceuticals Market

  • N. Rudholm
  • 2003
1 Excerpt

The Impact of Price Regulation on the Launch Delay of New DrugsEvidence from Twenty - Five Major Markets in the 1990 s ”

  • M. F. Furukawa
  • National Bureau of Economic Research Working…
  • 2003
2 Excerpts

The Dual Effects

  • J. P. Philipson
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…